Perella Weinberg Partners Capital Management LP Eli Lilly & CO Transaction History

Perella Weinberg Partners Capital Management LP

$935 Million
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $478,424 - $549,081	-6,320 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $272,202 - $321,316	-3,668 Reduced 36.72%	6,320 $489,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $818,416 - $877,845	9,988	9,988 $844,000

Others Institutions Holding LLY

# of Institutions

4,010

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$59 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.7 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$41.1 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27.1 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perella Weinberg Partners Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Perella Weinberg Partners Capital Management LP with notifications on news.

Account